Correlation Between Biomarin Pharmaceuticals and Uber Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceuticals and Uber Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceuticals and Uber Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceuticals and Uber Technologies, you can compare the effects of market volatilities on Biomarin Pharmaceuticals and Uber Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceuticals with a short position of Uber Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceuticals and Uber Technologies.

Diversification Opportunities for Biomarin Pharmaceuticals and Uber Technologies

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Biomarin and Uber Technologies is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceuticals and Uber Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uber Technologies and Biomarin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceuticals are associated (or correlated) with Uber Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uber Technologies has no effect on the direction of Biomarin Pharmaceuticals i.e., Biomarin Pharmaceuticals and Uber Technologies go up and down completely randomly.

Pair Corralation between Biomarin Pharmaceuticals and Uber Technologies

Given the investment horizon of 90 days Biomarin Pharmaceuticals is expected to generate 0.59 times more return on investment than Uber Technologies. However, Biomarin Pharmaceuticals is 1.7 times less risky than Uber Technologies. It trades about 0.04 of its potential returns per unit of risk. Uber Technologies is currently generating about -0.02 per unit of risk. If you would invest  7,616  in Biomarin Pharmaceuticals on August 31, 2022 and sell it today you would earn a total of  2,250  from holding Biomarin Pharmaceuticals or generate 29.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biomarin Pharmaceuticals  vs.  Uber Technologies

 Performance (%) 
       Timeline  
Biomarin Pharmaceuticals 
Biomarin Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Biomarin Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Biomarin Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2022.

Biomarin Price Channel

Uber Technologies 
Uber Technologies Performance
0 of 100
Over the last 90 days Uber Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Uber Technologies is not utilizing all of its potentials. The new stock price agitation, may contribute to short-term losses for the retail investors.

Uber Technologies Price Channel

Biomarin Pharmaceuticals and Uber Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomarin Pharmaceuticals and Uber Technologies

The main advantage of trading using opposite Biomarin Pharmaceuticals and Uber Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceuticals position performs unexpectedly, Uber Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uber Technologies will offset losses from the drop in Uber Technologies' long position.
Biomarin Pharmaceuticals vs. Abbvie Inc
Biomarin Pharmaceuticals vs. Abbott Laboratories
Biomarin Pharmaceuticals vs. Alkermes Plc
Biomarin Pharmaceuticals vs. Amgen Inc
The idea behind Biomarin Pharmaceuticals and Uber Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Uber Technologies vs. Salesforce
Uber Technologies vs. Snowflake Inc Cl
Uber Technologies vs. Intuit Inc
Uber Technologies vs. Cadence Design Sys
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go